Deregulation of protein methylation in melanoma.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Cancer

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2012.11.026PMID 23265702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ETS‐1/RhoC signaling regulates the transcription factor c‐Jun in melanoma

  2012cited by this paper
• Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase, an Exploitable Tumor Target

  2012cited by this paper
• Protein arginine methyltransferase 5 is an essential component of the hypoxia-inducible factor 1 signaling pathway.

  2012cited by this paper
• Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).

  2011cited by this paper
• Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Down-Regulation of Methylthioadenosine Phosphorylase ( MTAP ) Induces Progression of Hepatocellular Carcinoma via Accumulation of 5 =-Deoxy-5 =-Methylthioadenosine ( MTA )

  2011cited by this paper
• Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4.

  2011cited by this paper
• CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration

  2011cited by this paper
• CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.

  2011cited by this paper
• p54nrb is a new regulator of progression of malignant melanoma.

  2011cited by this paper
• Increased Sensitivity to Thiopurines in Methylthioadenosine Phosphorylase–Deleted Cancers

  2011cited by this paper
• A Coactivator Role of CARM1 in the Dysregulation of β-Catenin Activity in Colorectal Cancer Cell Growth and Gene Expression

  2011cited by this paper
• Versatility of PRMT5-induced methylation in growth control and development.

  2011cited by this paper
• Clinical evaluation of PRMT1 gene expression in breast cancer

  2011cited by this paper
• Arginine methylation-dependent regulation of ASK1 signaling by PRMT1

  2011cited by this paper
• Protein Arginine Methyltransferase 5 Regulates ERK1/2 Signal Transduction Amplitude and Cell Fate Through CRAF

  2011cited by this paper
• Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma

  2011cited by this paper
• Differential CARM1 expression in prostate and colorectal cancers

  2010cited by this paper
• Migration-associated secretion of melanoma inhibitory activity at the cell rear is supported by KCa3.1 potassium channels

  2010cited by this paper
• Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies.

  2010cited by this paper
• CARM1 but not its enzymatic activity is required for transcriptional coactivation of NF-kappaB-dependent gene expression.

  2009cited by this paper
• Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation.

  2009cited by this paper
• Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma

  2009cited by this paper
• Protein arginine methylation in mammals: who, what, and why.

  2009cited by this paper
• The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humans

  2009cited by this paper
• Direct and tumor microenvironment mediated influences of 5′‐deoxy‐5′‐(methylthio)adenosine on tumor progression of malignant melanoma

  2009cited by this paper
• Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma.

  2009cited by this paper
• Arginine methylation regulates the p53 response

  2008cited by this paper
• Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells

  2008cited by this paper
• JMJD6 Is a Histone Arginine Demethylase

  2007cited by this paper
• Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.

  2006cited by this paper
• Loss of Methylthioadenosine Phosphorylase and Elevated Ornithine Decarboxylase Is Common in Pancreatic Cancer

  2004cited by this paper
• Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen‐independent status

  2004cited by this paper
• Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.

  2003cited by this paper
• Inhibition of the tyrosine kinase activity of the fibroblast growth factor receptor by the methyltransferase inhibitor 5'-methylthioadenosine.

  1993cited by this paper
• Trends in the biochemical pharmacology of 5'-deoxy-5'-methylthioadenosine.

  1982cited by this paper

• PRMT6 Inhibits Malignant Progression of Melanoma by Antagonizing Trimethylation of Histone H3K4 to Downregulate ALDH1A1 Levels

  2025cites this paper
• TNFα activation of the PLEKHA5-FCRLA axis disturbs lipid metabolism, leading to the progression of cutaneous malignant melanoma

  2025cites this paper
• MTAP-Null Tumors: A Comprehensive Review on Synthetic Vulnerabilities and Therapeutic Strategies

  2025cites this paper
• PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt–β-catenin pathway

  2024cites this paper
• Yifei Sanjie formula alleviates lung cancer progression via regulating PRMT6‐YBX1‐CDC25A axis

  2024cites this paper
• The Tumor Metabolite 5′-Deoxy-5′Methylthioadenosine (MTA) Inhibits Maturation and T Cell-Stimulating Capacity of Dendritic Cells

  2024cites this paper
• MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors

  2024cites this paper
• The emerging role of CARM1 in cancer

  2024cites this paper
• Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.

  2024cites this paper
• A genome-wide association study for eumelanin pigmentation in chicken plumage using a computer vision approach.

  2023cites this paper
• Discovery of cysteine-targeting covalent histone methyltransferase inhibitors.

  2023cites this paper
• Prior information-assisted integrative analysis of multiple datasets

  2023cites this paper
• Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics.

  2023cites this paper
• Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss

  2023cites this paper
• The Emerging Role of PRMT6 in Cancer

  2022cites this paper
• Downregulation of MTAP promotes Tumor Growth and Metastasis by regulating ODC Activity in Breast Cancer

  2022cites this paper
• Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases

  2022cites this paper
• DNA or Protein Methylation-Dependent Regulation of Activator Protein-1 Function

  2021cites this paper
• CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator.

  2021cites this paper
• Structure, Activity and Function of the Protein Arginine Methyltransferase 6

  2021cites this paper
• Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death

  2020cites this paper
• PRMT6 serves an oncogenic role in lung adenocarcinoma via regulating p18

  2020cites this paper
• Discovery of a First-in-class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.

  2020cites this paper
• Peptidic transition state analogues as PRMT inhibitors.

  2020cites this paper
• PRMT6 promotes endometrial cancer via AKT/mTOR signaling and indicates poor prognosis.

  2019cites this paper
• PRMT Inhibitors

  2019cites this paper
• Characterising protein arginine methylation in glioblastoma cell lines : implications for brain cancer

  2019cites this paper
• Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

  2019cites this paper
• Epigenetic Modulators

  2018cites this paper
• Cancer II

  2018cites this paper
• PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.

  2018cites this paper
• Driver genes in CTCL : a genomic approach for screening and a detailed analysis of a candidate gene

  2017cites this paper
• The Effect of Different Types of Nanoparticles on FUS and TDP-43 Solubility and Subcellular Localization

  2017cites this paper
• PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.

  2017cites this paper
• Inhibitors of Protein Methyltransferases and Demethylases

  2017cites this paper
• Histone Modifications and Cancer.

  2016cites this paper
• Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

  2016cites this paper
• Characterization of arginine methyltransferase PRMT8 in cells with increased plasticity

  2016cites this paper
• Understanding P-glycoprotein mediated multidrug resistance in cancer: new potential targets, biomarkers and molecular inhibitors

  2016cites this paper
• Therapeutic targeting of methylthioadenosine phosphorylase

  2016cites this paper
• Methylthioadenosine (MTA) Regulates Liver Cells Proteome and Methylproteome: Implications in Liver Biology and Disease*

  2016cites this paper
• Suppressive effects of tumor cell-derived 5′-deoxy-5′-methylthioadenosine on human T cells

  2016cites this paper
• Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.

  2016cites this paper
• Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.

  2016cites this paper
• A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.

  2016cites this paper
• Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954 - Incidence and Effects on Enzymatic Function in Malignant Melanoma

  2016cites this paper
• Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer *

  2015cites this paper
• Structural and Kinetic Characterization of a Novel N-acetylated Aliphatic Amine Metabolite of the PRMT Inhibitor, EPZ011652

  2015cites this paper
• EZH2: an emerging role in melanoma biology and strategies for targeted therapy

  2015cites this paper
• Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine.

  2015cites this paper
• PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer*

  2015cites this paper
• Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound.

  2015cites this paper
• Inhibition de prmt5 dans le traitement de maladies liées à une déficience en mtap

  2015cites this paper
• Investigating the Role of Protein Arginine Methyltransferases in Breast Cancer Etiology

  2015cites this paper
• Caracterización de los mecanismos implicados en las alteraciones fisiopatológicas inducidas por una deficiencia de metiltioadenosina fosforilasa en células hepáticas

  2015influential citation
• PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer.

  2014cites this paper
• Tumor and Stem Cell Biology PRMT 7 Induces Epithelial-to-Mesenchymal Transition and Promotes Metastasis in Breast Cancer

  2014cites this paper
• PELP1 oncogenic functions involve alternative splicing via PRMT6

  2014cites this paper
• Targeting the epigenetic machinery of cancer cells

  2014cites this paper
• The metabolite 5'-methylthioadenosine signals through the adenosine receptor A2B in melanoma.

  2014cites this paper
• TMEFF2 and SARDH cooperate to modulate one‐carbon metabolism and invasion of prostate cancer cells

  2013cites this paper
• Peptide-based probes for protein N-Methyltransferases

  year unknowncites this paper
• PRMT 1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT 1 knockdown downregulates proliferation and migration of oral cancer cells

  year unknowncites this paper
• Peptide-based probes for protein N-Methyltransferases

  year unknowncites this paper